1. Home
  2. TKC vs BLCO Comparison

TKC vs BLCO Comparison

Compare TKC & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turkcell Iletisim Hizmetleri AS

TKC

Turkcell Iletisim Hizmetleri AS

HOLD

Current Price

$5.91

Market Cap

5.2B

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.90

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKC
BLCO
Founded
1993
1853
Country
Turkey
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Ophthalmic Goods
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
6.0B
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
TKC
BLCO
Price
$5.91
$16.90
Analyst Decision
Hold
Analyst Count
0
14
Target Price
N/A
$17.31
AVG Volume (30 Days)
903.5K
351.6K
Earning Date
11-06-2025
10-29-2025
Dividend Yield
3.96%
N/A
EPS Growth
N/A
N/A
EPS
0.11
N/A
Revenue
$4,451,876,110.00
$4,976,000,000.00
Revenue This Year
$42.76
$8.08
Revenue Next Year
$29.15
$5.77
P/E Ratio
$22.64
N/A
Revenue Growth
N/A
6.23
52 Week Low
$5.35
$10.45
52 Week High
$7.63
$18.99

Technical Indicators

Market Signals
Indicator
TKC
BLCO
Relative Strength Index (RSI) 53.05 58.82
Support Level $5.86 $16.83
Resistance Level $6.15 $17.33
Average True Range (ATR) 0.07 0.45
MACD 0.02 -0.00
Stochastic Oscillator 52.53 52.69

Price Performance

Historical Comparison
TKC
BLCO

About TKC Turkcell Iletisim Hizmetleri AS

Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes high-quality mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Turkcell International, and Techfin. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: